Matter
KBP Biosciences Pte Ltd and another v Novo Nordisk A/S
Dispute over alleged fraud in Novo Nordisk's acquisition of Ocedurenone, with Singapore worldwide freezing relief supporting a New York-seated ICC arbitration.
Procedural record
- 14 February 2025Singapore
14 February 2025Singapore
Judgment of the Singapore International Commercial Court in the case Originating Application No 3 of 2025 and Summons No 11 of 2025 dated 14 February 2025
Singapore International Commercial Court
- Citation
- [2025] SGHC(I) 3
- Decision summary
- The court granted a worldwide freezing order and ancillary asset-disclosure orders against KBP Biosciences Pte. Ltd. and Huang Zhenhua in support of Novo Nordisk A/S's intended New York-seated ICC arbitration. It found a good arguable fraud case and a real risk of asset dissipation, and held that the foreign seat did not make urgent relief inappropriate: the defendants had significant Singapore assets, no tribunal had been constituted, and an ICC emergency arbitrator could not act without notice. The undertakings were revised to permit Cayman Islands proceedings to give effect to or enforce the freezing order. The court made no order on confidentiality and reserved costs.
Participants
- Application
- Ex parte application for a worldwide freezing order in support of a New York-seated arbitration — Granted, with revised undertakings permitting Cayman Islands implementation or enforcement proceedings
- Application
- Ancillary asset-disclosure orders — Granted
- Application
- Confidentiality orders — No order
Novo Nordisk A/S
- Representative
- Ong Tun Wei Danny (For: Novo Nordisk A/S)
- Representative
- Teo Jason (For: Novo Nordisk A/S)
- Representative
- Zhang Haowei Elvis (For: Novo Nordisk A/S)
- Representative
- Setia Law LLC (For: Novo Nordisk A/S)
KBP Biosciences Pte. Ltd.
Huang Zhenhua
Singapore International Commercial Court
- Judge
- Philip Jeyaretnam
Other
- Witness
- Peter Billeskov Schelde
1 year and 3 months later · 454 days
- 14 May 2026Singapore
14 May 2026Singapore
Judgment of the Court of Appeal of Singapore in the case [2026] SGCA(I) 2 dated 14 May 2026
Court of Appeal of Singapore
- Decision summary
- The court dismissed the appeal and upheld the refusal to set aside the worldwide freezing order, subject to a minor variation that was not appealed. It held that section 12A of Singapore's International Arbitration Act 1994 empowered the court to grant urgent interim relief in support of the New York-seated arbitration because the arbitral tribunal could not act effectively at the relevant time.
Participants
KBP Biosciences Pte Ltd
- Representative
- Mr Cavinder Bull SC (For: KBP Biosciences Pte Ltd · Dr Huang Zhenhua)
Dr Huang Zhenhua
- Representative
- Mr Cavinder Bull SC (For: KBP Biosciences Pte Ltd · Dr Huang Zhenhua)
Novo Nordisk A/S
- Representative
- Mr Ong Tun Wei Danny SC (For: Novo Nordisk A/S)
Court of Appeal of Singapore
- Judge
- Judith Prakash SJ
- Judge
- Lady Arden IJ
- Judge
- Philip Jeyaretnam J